These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21097981)

  • 1. Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline.
    Turner JR; Castellano LM; Blendy JA
    Nicotine Tob Res; 2011 Jan; 13(1):41-6. PubMed ID: 21097981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
    Hussmann GP; DeDominicis KE; Turner JR; Yasuda RP; Klehm J; Forcelli PA; Xiao Y; Richardson JR; Sahibzada N; Wolfe BB; Lindstrom J; Blendy JA; Kellar KJ
    J Neurochem; 2014 May; 129(4):721-31. PubMed ID: 24422997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
    Turner JR; Wilkinson DS; Poole RL; Gould TJ; Carlson GC; Blendy JA
    Neuropsychopharmacology; 2013 Sep; 38(10):2035-47. PubMed ID: 23624742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.
    Hussmann GP; Turner JR; Lomazzo E; Venkatesh R; Cousins V; Xiao Y; Yasuda RP; Wolfe BB; Perry DC; Rezvani AH; Levin ED; Blendy JA; Kellar KJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):441-50. PubMed ID: 22899752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum.
    Bordia T; Hrachova M; Chin M; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2012 Aug; 342(2):327-34. PubMed ID: 22550286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
    Ortiz NC; O'Neill HC; Marks MJ; Grady SR
    Nicotine Tob Res; 2012 Jun; 14(6):711-9. PubMed ID: 22241831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship of Varenicline Agonism of α4β2 Nicotinic Acetylcholine Receptors and Nicotine-Induced Dopamine Release in Nicotine-Dependent Humans.
    McCaul ME; Wand GS; Kuwabara H; Dannals RF; Wong D; Xu X
    Nicotine Tob Res; 2020 May; 22(6):892-899. PubMed ID: 31096265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation.
    Gould TJ; Portugal GS; André JM; Tadman MP; Marks MJ; Kenney JW; Yildirim E; Adoff M
    Neuropharmacology; 2012 Apr; 62(5-6):2118-25. PubMed ID: 22285742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice.
    Bagdas D; Alkhlaif Y; Jackson A; Carroll FI; Ditre JW; Damaj MI
    Neuropharmacology; 2018 Aug; 138():72-79. PubMed ID: 29860196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
    Coe JW; Brooks PR; Vetelino MG; Wirtz MC; Arnold EP; Huang J; Sands SB; Davis TI; Lebel LA; Fox CB; Shrikhande A; Heym JH; Schaeffer E; Rollema H; Lu Y; Mansbach RS; Chambers LK; Rovetti CC; Schulz DW; Tingley FD; O'Neill BT
    J Med Chem; 2005 May; 48(10):3474-7. PubMed ID: 15887955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
    Cunningham CS; McMahon LR
    Eur J Pharmacol; 2011 Mar; 654(1):47-52. PubMed ID: 21172344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
    Rollema H; Hurst RS
    Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual differences in amygdala reactivity following nicotinic receptor stimulation in abstinent smokers.
    Sutherland MT; Carroll AJ; Salmeron BJ; Ross TJ; Hong LE; Stein EA
    Neuroimage; 2013 Feb; 66():585-93. PubMed ID: 23110878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of varenicline for smoking cessation.
    Hays JT; Ebbert JO; Sood A
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids.
    Cunningham CS; McMahon LR
    Psychopharmacology (Berl); 2013 Jul; 228(2):321-33. PubMed ID: 23494230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline but not cotinine increased the value of a visual stimulus reinforcer in rats: No evidence for synergy of the two compounds.
    Houser SD; McNealy KR; Barrett ST; Bevins RA
    Pharmacol Biochem Behav; 2024 Feb; 235():173702. PubMed ID: 38154590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interactions of varenicline and nicotine with nAChR subtypes implicated in cardiovascular control.
    Rollema H; Russ C; Lee TC; Hurst RS; Bertrand D
    Nicotine Tob Res; 2014 Jun; 16(6):733-42. PubMed ID: 24406270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers.
    Sutherland MT; Carroll AJ; Salmeron BJ; Ross TJ; Hong LE; Stein EA
    Biol Psychiatry; 2013 Oct; 74(7):538-46. PubMed ID: 23506999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.
    Lesage E; Aronson SE; Sutherland MT; Ross TJ; Salmeron BJ; Stein EA
    JAMA Psychiatry; 2017 Jun; 74(6):632-640. PubMed ID: 28403383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.